US 10717993
Methods and compositions for increased transgene expression
granted A61PA61P1/02A61P1/04
Quick answer
US patent 10717993 (Methods and compositions for increased transgene expression) held by Sangamo Therapeutics, Inc. expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P11/06